What is CergenX?
Based in Cork, Ireland, CergenX is a medtech company specializing in newborn-focused screening systems. The company is positioned to make significant advancements in early detection and intervention for newborns through its innovative technology.
How much funding has CergenX raised?
CergenX has raised a total of $1.3M across 1 funding round:
Other Financing Round
$1.3M
Other Financing Round (2023): $1.3M with participation from Enterprise Ireland
Key Investors in CergenX
Enterprise Ireland
Enterprise Ireland is a government agency focused on the development and growth of Irish businesses in manufacturing and internationally traded services, indicating a strategic interest in fostering innovation within Ireland.
What's next for CergenX?
The recent major strategic investment signals a pivotal growth phase for CergenX. This capital infusion is expected to accelerate product development, expand market reach, and further solidify CergenX's position as a leader in neonatal screening technology. The company is poised for further innovation and scaling in the critical medtech landscape.
See full CergenX company page